Cited by 207Computational Drug Discovery MethodsProtein Structure and Dynamicsvaccines and immunoinformatics approaches

D3R grand challenge 2015: evaluation of protein-ligand pose and affinity predictions.

Open access
Gathiaka, Symon, Liu, Shuai, Chiu, Michael, Yang, Huanwang, Stuckey, Jeanne A., Kang, You Na, Delproposto, Jim, Kubish, Ginger +7 more·2016·Journal of Computer-Aided Molecular Design

Abstract

The Drug Design Data Resource (D3R) ran Grand Challenge 2015 between September 2015 and February 2016. Two targets served as the framework to test community docking and scoring methods: (1) HSP90, donated by AbbVie and the Community Structure Activity Resource (CSAR), and (2) MAP4K4, donated by Genentech. The challenges for both target datasets were conducted in two stages, with the first stage testing pose predictions and the capacity to rank compounds by affinity with minimal structural data; and the second stage testing methods for ranking compounds with knowledge of at least a subset of the ligand-protein poses. An additional sub-challenge provided small groups of chemically similar HSP90 compounds amenable to alchemical calculations of relative binding free energy. Unlike previous blinded Challenges, we did not provide cognate receptors or receptors prepared with hydrogens and likewise did not require a specified crystal structure to be used for pose or affinity prediction in Stage 1. Given the freedom to select from over 200 crystal structures of HSP90 in the PDB, participants employed workflows that tested not only core docking and scoring technologies, but also methods for addressing water-mediated ligand-protein interactions, binding pocket flexibility, and the optimal selection of protein structures for use in docking calculations. Nearly 40 participating groups submitted over 350 prediction sets for Grand Challenge 2015. This overview describes the datasets and the organization of the challenge components, summarizes the results across all submitted predictions, and considers broad conclusions that may be drawn from this collaborative community endeavor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10822-016-9946-8

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [17]Wang L Stanley M Boggs JW 2014 Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors Bioorg Med Chem Lett 24 4546 52 10.1016/j.bmcl.2014.07.071 25139565 · DOI
  2. [21]Tembre BL Mc Cammon JA 1984 Ligand-receptor interactions Comput Chem 8 281 283 http://dx.doi.org/10.1016/0097-8485(84)85020-2 · DOI

Cited by

Sorted by citations

Authors
Gathiaka, S., Liu, S., Chiu, M., Yang, H., Stuckey, J. A., Kang, Y. N., Delproposto, J., Kubish, G., Dunbar, J. B., Carlson, H. A., Burley, S. K., Walters, W. P., Amaro, R. E., Feher, V. A., & Gilson, M. K.
Affiliations
  • University of California San Diego (US)
  • Rutgers, The State University of New Jersey (US)
  • University of Michigan (US)
  • Relay Therapeutics (United States) (US)
  • Schrodinger (United States) (US)
Corresponding author
  • Amaro, Rommie E.
  • Feher, Victoria A.
  • Gilson, Michael K.
Venue
Journal of Computer-Aided Molecular Design
Published
2016-09
Volume
30
Issue
9
Pages
651-668
ISSN
  • 0920-654X (ISSN-L)
  • 1573-4951
OpenAlex
W2527541313
Cited by
207
References
39
Citations by year
2026: 13 · 2025: 11 · 2024: 11 · 2023: 17 · 2022: 17 · 2021: 22 · 2020: 30 · 2019: 29 · 2018: 24 · 2017: 32 · 2016: 1
FWCI
26.68
Type
journal article
Language
en
Open access
Locations
  • Journal of Computer-Aided Molecular Design (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institute of General Medical Sciences (1U01GM111528)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
protein-ligand docking, binding affinity prediction, HSP90, MAP4K4, pose prediction, compound ranking, alchemical free energy calculations, water-mediated interactions
MeSH terms
Binding Sites, Ligands, Protein Binding, Protein Conformation, Drug Design, Crystallography, X-Ray, HSP90 Heat-Shock Proteins, Quantitative Structure-Activity Relationship, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review